以色列 - 希伯来文 - Ministry of Health

pfizer pharmaceuticals israel ltd - encephalitis, tick borne, inactivated, whole virus - תרחיף להזרקה - encephalitis, tick borne, inactivated, whole virus 1.2 mcg / 0.25 ml - encephalitis, tick borne, inactivated, whole virus

以色列 - 希伯来文 - Ministry of Health

ד.ט.י. שירותי אופטיקה בע"מ - רופא - מכשירים לבדיקה ולאבחון מבנה העין והראייה- לא חודרני / לא פולשני

以色列 - 希伯来文 - Ministry of Health

teva israel ltd - methylbenzethonium chloride; paromomycin as sulfate - משחה - methylbenzethonium chloride 12 %w/w; paromomycin as sulfate 15 %w/w - paromomycin - paromomycin - topical treatment of cutaneous leishmaniasis.

以色列 - 希伯来文 - Ministry of Health

medic trim healthcare ltd - amikacin as sulfate 100 mg / 2 ml - solution for injection - amikacin - treatment of serious nosocomial gram-negative bacillary and in some gram-positive infections in hospitals where resistance to gentamicin and tobramycin has been found

以色列 - 希伯来文 - Ministry of Health

medic trim healthcare ltd - amikacin as sulfate 500 mg / 2 ml - solution for injection - amikacin - treatment of serious nosocomial gram-negative bacillary and in some gram-positive infections in hospitals where resistance to gentamicin and tobarmicin has been found

以色列 - 希伯来文 - Ministry of Health

glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus - אבקה וממס להכנת תמיסה להזרקה - live attenuated mumps virus 10^3.7 ccid50; live attenuated rubella virus 10^3.0 ccid50; live attenuated measles virus 10^3.0 ccid50 - rubella, combinations with mumps, live attenuated - rubella, combinations with mumps, live attenuated - priorix is indicated for active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella.

以色列 - 希伯来文 - Ministry of Health

glaxo smith kline (israel) ltd - varicella virus, live attenuated - אבקה וממס להכנת תמיסה להזרקה - varicella virus, live attenuated nlt 10^3.3 pfu - varicella zoster vaccines - in the event of negative anamnesis, for the active immunisation against varicella in healthy subjects only from the age of 12 months.